Los Gatos, CA, United States of America

Eric F Connor

USPTO Granted Patents = 44 

 

 

Average Co-Inventor Count = 6.4

ph-index = 13

Forward Citations = 474(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
44 patents (USPTO):

Title: The Innovative Contributions of Eric F. Connor in Pharmaceutical Patents

Introduction

Eric F. Connor, a prolific inventor based in Los Gatos, CA, has made significant strides in the field of pharmaceuticals, holding an impressive 43 patents to his name. His work primarily focuses on compositions and methods that address critical acid-base disorders, showcasing a commitment to innovation in healthcare.

Latest Patents

Among Connor's notable patents are:

1. **Compositions for and methods of treating acid-base disorders** - This patent describes pharmaceutical compositions intended for both human and animal use, particularly aimed at treating diseases where the removal of protons and strong acids from the gastrointestinal tract is beneficial. The compositions work to normalize serum bicarbonate concentrations and blood pH levels.

2. **Proton-binding polymers for oral administration** - This innovation involves crosslinked amine polymers aimed at offering physiological benefits by removing protons and chloride ions, thereby assisting in regulating blood pH and serum bicarbonate levels in the gastrointestinal tract.

Career Highlights

Throughout his career, Eric F. Connor has been associated with reputable companies like Relypsa, Inc. and Tricida, Inc., where he contributed to advancing pharmaceutical research and development efforts. His extensive patent portfolio underscores his enduring impact on the field.

Collaborations

Connor's collaborative efforts with prominent professionals in his field, including Michael James Cope and Dominique Charmot, have undoubtedly enriched his work. These partnerships have cultivated a dynamic environment conducive to innovation and precision in pharmaceutical treatments.

Conclusion

Eric F. Connor's dedication to developing innovative pharmaceutical solutions illustrates the vital role of inventors in addressing healthcare challenges. His contributions not only enhance the scientific community but also improve patient outcomes, establishing him as a prominent figure in the landscape of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…